Results 201 to 210 of about 14,172 (227)
Some of the next articles are maybe not open access.
Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012In a study performed in Cambodia, a higher number of tuberculosis (TB) strains with mutations in the pncA gene associated with pyrazinamide resistance (PZA-R) was found in fluoroquinolone-resistant (FQ-R) multidrug-resistant (MDR) strains (93%), compared with 47% in MDR and 3% in non-MDR strains.
C, Pierre-Audigier +7 more
openaire +1 more source
Journal of Chemotherapy, 2007
The emergence of multidrug-resistant (MDR) Mycobacterium tuberculosis (Mtb) strains, i.e. strains resistant at least to isoniazid (INH) and rifampin (RMP), the two most powerful first-line drugs for the treatment of tuberculosis (TB), represents a worldwide health care problem.
Pardini M. +19 more
openaire +2 more sources
The emergence of multidrug-resistant (MDR) Mycobacterium tuberculosis (Mtb) strains, i.e. strains resistant at least to isoniazid (INH) and rifampin (RMP), the two most powerful first-line drugs for the treatment of tuberculosis (TB), represents a worldwide health care problem.
Pardini M. +19 more
openaire +2 more sources
No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance
The International Journal of Tuberculosis and Lung Disease, 2016Cobelens, Frank +2 more
openaire +2 more sources
Resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones
The Lancet Infectious Diseases, 2017Ling, Chen, Hong, Zhang
openaire +2 more sources
[Resistance to pyrazinamide in tuberculosis patients].
Enfermedades infecciosas y microbiologia clinica, 1991M, Casal, M J, Linares, N, Marín
openaire +1 more source

